In one paragraphReview in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
22 authors.
Genevieve EdoborDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0000-0001-6330-7745 Ronald HuberDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0009-0000-4375-9699 Christoph ReiterDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0009-0009-1666-8842 Hanna GerckeDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0009-0003-2215-6065 Niklas KaeferDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0009-0008-0146-3046 Elli KronsteinerDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0009-0007-4532-5676 Bjoern WimmerDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0000-0002-9969-1256 Marlies WimmerDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0000-0003-2650-1332 Thomas KarlDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0000-0001-8730-5330 Mark RinnerthalerDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0000-0003-1190-0584 Jan KraußDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0000-0003-2040-5008 Heinrich KrobathInstitute for Theoretical Physics, Johannes Kepler University Linz, 4020 Linz, Austria.ORCID 0000-0001-6473-8109 Thomas MohrDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-1933-847X Christopher GernerDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-4964-0642 Helmut HintnerDepartment of Dermatology and Allergology, University Hospital Salzburg, Muellner Hauptstraße 48, 5020 Salzburg, Austria.ORCID 0000-0001-9199-0991 Bernadette LiembergerEB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Muellner Hauptstraße 48, 5020 Salzburg, Austria.ORCID 0000-0002-1056-362X Ulrich KollerEB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Muellner Hauptstraße 48, 5020 Salzburg, Austria.ORCID 0000-0002-6285-1789 Johann W BauerDepartment of Dermatology and Allergology, University Hospital Salzburg, Muellner Hauptstraße 48, 5020 Salzburg, Austria.ORCID 0000-0002-6085-9170 Hannelore Breitenbach-KollerDepartment of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.ORCID 0000-0002-8387-6408 Funding
Land Salzburg P/147200/30
6 · The paper itselfAbstract
Across all kingdoms of life, ribosomes are indispensable molecular machines that translate genetic information into the proteome of living cells. The fundamental catalytic centers of the ribosome, constructed primarily from ribosomal RNA (rRNA), exhibit remarkable conservation between the major domains of life. The ribosome's A-site deciphers the mRNA's triplet code, while the P-site synthesizes the growing protein chain and the E-site provides exit for deacylated tRNA; a distinct tunnel facilitates nascent polypeptide export. While the conservation of ribosomal proteins is less pronounced between bacteria and eukaryotes, striking homology exists from simple eukaryotes to humans. Ribosomal proteins were traditionally viewed mainly as scaffolding agents, steering rRNA folding during ribosome biogenesis and maintaining structural stability during translation. However, since the early 2000s, advances in structural and functional ribosome analysis have ushered in a more nuanced paradigm: ribosomes are no longer considered uniform machines. Instead, an array of rRNA and ribosomal protein modifications generates a spectrum of ribosome populations capable of specialized translation. RiboScreen
Indexed as
customized protein productionnovel drug targetsprecision intervention in rare and prevalent diseaseRiboScreenTMribosomal proteins
Identifiers
PMID42511894
PMCPMC13404128
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390